Korten Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 1990.
1990 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Korten Pharmaceuticals Private Limited

Korten Pharmaceuticals Private Limited, a active private limited company, was established on 05 November 1990 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1990PTC058797. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.

It upholds a compliant status. Employing 184 professional, Its leadership includes Rahul Ashokkumar Jain (Director), Uttamchand Kesharimal Jain (Director), Pravin Keshrimal Jain (Director). Past directors included Madhav Laxman Deshpande, Neelam Sandeep Mhatre, Kirti Shantilal Sheth. It holds ₹1.40 Cr open charges and ₹50.42 Cr settled loans. Its latest AGM occurred on 19 September 2025, with the balance sheet filed on 31 March 2025. It is based at Gala No.40,Damji Shamji Industrial Complex Mahakali Caves Road, Andheri East, Mumbai, Maharashtra, 400093.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1990PTC058797

  • Registration Number

    058797

  • Incorporation Date

    05 November 1990

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹3.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 3.00 Cr
  • Company Age 35 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.40 Cr
  • Satisfied Charges ₹ 50.42 Cr
  • Revenue Growth **** 28.73%
  • Profit Growth **** 103.91%
  • Ebitda **** 105.70%
  • Net Worth 31.10%
  • Total Assets **** 9.52%
Company report

Korten Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Korten Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Korten Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rahul Ashokkumar Jain Director 05 Jan 2013 Current
Uttamchand Kesharimal Jain Director 05 Jan 2013 Current
Pravin Keshrimal Jain Director 15 Feb 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 18 Mar 2013 Past
Pramod Abcsdd Director 11 Jul 2014 Past
Pramod Abcsdd Managing Director 31 Mar 2008 Past
Pramod Abcsdd Company Secretary 06 Apr 2008 Past
Pramod Abcsdd Director 18 Mar 2013 Past
Pramod Abcsdd Additional Director 27 Sep 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Korten Pharmaceuticals.

Korten Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 28.73% increase. The company also saw a substantial improvement in profitability, with a 103.91% increase in profit. The company's net worth Soared by an impressive increase of 31.1%.

Korten Pharmaceuticals revenue growth over time
Korten Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 28.73%
*******
*******
*******
*******
Revenue from Operations
*******
 28.76%
*******
*******
*******
*******
Total Assets
*******
 9.52%
*******
*******
*******
*******
Profit or Loss
*******
 103.91%
*******
*******
*******
*******
Net Worth
*******
 31.10%
*******
*******
*******
*******
EBITDA
*******
 105.70%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Korten Pharmaceuticals?

In 2024, Korten Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹14,000,000.00

Satisfied Charges

₹504,248,000.00

Charges Breakdown by Lending Institutions
  • The Hongkong And Shanghai Banking Corporation Limited : 1.40 Cr
Latest Charge Details
Date Lender Amount Status
05 Feb 1996 The Hongkong And Shanghai Banking Corporation Limited ₹5.00 M Open
05 Feb 1996 The Hongkong And Shanghai Banking Corporation Limited ₹5.00 M Open
02 Nov 1994 The Hongkong And Shanghai Banking Corporation Limited ₹4.00 M Open
04 Jul 2019 Others ₹1.85 Cr Satisfied
05 Nov 2016 Others ₹2.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Korten Pharmaceuticals?

Korten Pharmaceuticals has a workforce of 184 employees as of Mar 18, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Korten Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Korten Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Korten Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Korten Pharmaceuticals Private Limited last Annual general meeting of members was held on 19 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Korten Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Charges

    Progress on A charge registered on 28 Feb 1995 via Charge ID 90152463 with Maharashtra State Financial Corporation was fully satisfied on 30 Aug 2022. was documented.

  • Charges

    The activity A charge registered on 28 Jun 2002 via Charge ID 90153903 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 24 Jun 2021. was completed.

  • Charges

    A charge registered on 22 Sep 2001 via Charge ID 90153842 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 24 Jun 2021. was recorded as a recent event.

  • Charges

    The activity A charge registered on 20 Sep 2001 via Charge ID 90154654 with Janakalyan Sahakari Bank Ltd. was fully satisfied on 24 Jun 2021. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Korten Pharmaceuticals Private Limited?

The CIN of Korten Pharmaceuticals Private Limited is U24239MH1990PTC058797.

Where is Korten Pharmaceuticals Private Limited headquartered?

Korten Pharmaceuticals Private Limited is headquartered at Gala No.40,Damji Shamji Industrial Complex Mahakali Caves Road, Andheri East, Mumbai, Maharashtra, 400093.

When was Korten Pharmaceuticals Private Limited incorporated?

Korten Pharmaceuticals Private Limited was incorporated on 05 November 1990.

Who are the current directors of Korten Pharmaceuticals Private Limited?

The current directors of Korten Pharmaceuticals Private Limited are

What is the primary industry of Korten Pharmaceuticals Private Limited?

The primary industry of Korten Pharmaceuticals Private Limited is Manufacturing.

Is Korten Pharmaceuticals Private Limited a listed company?

Korten Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Korten Pharmaceuticals Private Limited?

The authorized capital of Korten Pharmaceuticals Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.

What is the compliance status of Korten Pharmaceuticals Private Limited?

The compliance status of Korten Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available